Robertson Stephens Wealth Management, LLC Moderna, Inc. Transaction History

Robertson Stephens Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $33,915 - $49,255	250 Added 15.43%	1,870 $287,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $191,775 - $340,264	1,620 New	1,620 $290,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $2,811 - $4,238	24 Added 1.46%	1,669 $238,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $41,325 - $67,437	183 Added 12.52%	1,645 $417,000
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $75,889 - $165,688	342 Added 30.54%	1,462 $562,000
Q2 2021 Aug 17, 2021	BUY	$129.91 - $234.98 $145,499 - $263,177	1,120 New	1,120 $263,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.